These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25735476)

  • 41. Nerve Ultrasound Performances in Differentiating POEMS Syndrome from CIDP.
    Niu J; Ding Q; Fan J; Zhang L; Liu J; Guan Y; Wu S; Cui L; Liu M
    Neurotherapeutics; 2022 Mar; 19(2):455-463. PubMed ID: 35257327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [POEMS syndrome as a rare cause of bilateral optic disc edema].
    Birkenbach A; Kühlhorn F; Grube M; Helbig H; Gamulescu MA
    Ophthalmologe; 2017 Mar; 114(3):262-265. PubMed ID: 27364634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of age on excitability properties in human motor axons.
    Bae JS; Sawai S; Misawa S; Kanai K; Isose S; Shibuya K; Kuwabara S
    Clin Neurophysiol; 2008 Oct; 119(10):2282-6. PubMed ID: 18760964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
    Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
    BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome.
    Soubrier M; Sauron C; Souweine B; Larroche C; Wechsler B; Guillevin L; Piette JC; Rousset H; Deteix P
    Am J Kidney Dis; 1999 Oct; 34(4):633-8. PubMed ID: 10516342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nerve ultrasound studies in POEMS syndrome.
    Ding Q; Li J; Guan Y; Wu S; Niu J; Shen D; Hu Y; Wu Y; Liu M; Cui L
    Muscle Nerve; 2021 May; 63(5):758-764. PubMed ID: 33604886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Axonal excitability properties in hemifacial spasm.
    Krishnan AV; Hayes M; Kiernan MC
    Mov Disord; 2007 Jul; 22(9):1293-8. PubMed ID: 17486620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
    Miralles GD; O'Fallon JR; Talley NJ
    N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. POEMS syndrome with Guillan-Barre syndrome-like acute onset: a case report and review of neurological progression in 30 cases.
    Isose S; Misawa S; Kanai K; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Nakaseko C; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):678-80. PubMed ID: 20562460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The POEMS syndrome: report of six cases.
    Pareyson D; Marazzi R; Confalonieri P; Mancardi GL; Schenone A; Sghirlanzoni A
    Ital J Neurol Sci; 1994 Oct; 15(7):353-8. PubMed ID: 7698893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The natural history of a "benign" rib lesion in a patient with a demyelinating polyneuropathy and an unusual variant of POEMS syndrome.
    Simmons Z; Wald J; Albers JW; Feldman EL
    Muscle Nerve; 1994 Sep; 17(9):1055-9. PubMed ID: 8065392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [POEMS syndrome: role and value of interleukin-6].
    Andrès E; Courouau F; Kaltenbach G; Maloisel F; Imler M
    Rev Med Interne; 1996; 17(2):145-9. PubMed ID: 8787086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. POEMS syndrome: importance of the clinical laboratory practitioner's role.
    Levinson SS
    Clin Chim Acta; 2012 Nov; 413(21-22):1800-7. PubMed ID: 22771968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China.
    Li J; Zhou DB; Huang Z; Jiao L; Duan MH; Zhang W; Zhao YQ; Shen T
    Ann Hematol; 2011 Jul; 90(7):819-26. PubMed ID: 21221584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [POEMS syndrome: a contribution to differential diagnosis of polyneuropathy].
    Dressnandt J; Näher-Noé M; Drosner M; Klingelhöfer J
    Nervenarzt; 1993 Apr; 64(4):258-62. PubMed ID: 8506014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy of autologous peripheral blood stem cell transplantation (auto-PBSCT) on the neuropathic manifestations in POEMS syndrome].
    Gronier S; Delmont E; Legros L; Launay M; Jeandel PY; Fuzibet JG; Desnuelle C
    Rev Neurol (Paris); 2014 Jan; 170(1):37-45. PubMed ID: 24411685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [POEMS syndrome: a review of the literature].
    Méndez-Herrera CR; Cordoví-Rodríguez D
    Rev Neurol; 2011 Jul; 53(1):44-50. PubMed ID: 21678324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A rat in vitro model for the measurement of multiple excitability properties of cutaneous axons.
    Maurer K; Bostock H; Koltzenburg M
    Clin Neurophysiol; 2007 Nov; 118(11):2404-12. PubMed ID: 17897875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Axonal excitability properties in amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2006 Jul; 117(7):1458-66. PubMed ID: 16759905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.